Switzerland· 51750002
Insulin Lilly Huminsulin Basal cartouches 3,0 ml, suspension injectable
A insulin (human) product, registered in Switzerland by Eli Lilly (Suisse) SA and dispensed under Swissmedic category B. The same ATC class is registered in 11 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Insulin (human) is registered in 11 of 19 countries.
Countries holding a registration under ATC A10AC01 (insulin (human)), each read from that country’s own register.
- This record: Switzerland
- 7 of them publish a price we can compare per daily dose
Insulin (human) · ATC A10AC01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
- Manufacturer
- Eli Lilly (Suisse) SA
- Country
- Switzerland (CH)
- ATC code
- A10AC01
- ATC class
- Insulin (human)
- Defined daily dose
- 40 E, P
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
460 interactions on record for insulin (human).
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Insulin (human) · interactions on record
460 records
- 15 severe
- 395 moderate
- 50 minor
Most severe, free to view
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- PrednisoloneA07EA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A10AC01
Insulin (human), as other registers publish it.
- PolandGensulin NBioton S.A.
- PolandGensulin NBioton S.A.
- SwitzerlandHuminsulin Basal
- SwitzerlandHuminsulin Basal KwikPen
- IrelandHumulin I (Isophane) 100 IU/ml Suspension for Injection in cartridgeEli Lilly Nederland B.V.
- IrelandHumulin I (Isophane) 100 IU/ml Suspension for Injection in vialEli Lilly Nederland B.V.
- IrelandHumulin I KwikPen (Isophane) 100 IU/ml Suspension for InjectionEli Lilly Nederland B.V.
- PolandHumulin NEli Lilly Nederland B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb6f2aae-ffb0-4736-afa2-5f5fd0ff5526 GET /v1/drugs/fb6f2aae-ffb0-4736-afa2-5f5fd0ff5526?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Biotechnologika"
}See everything about insulin (human).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.